SCHEMBL7192086

SCHEMBL7192086

C=CC(C)(C)c1ccc(OCC)c(/C=C/C(=O)c2ccc(N)cc2)c1OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 8/20 0.42
IDH1 O75874 1/20 0.41
ABCB1 P08183 1/20 0.41
UGT1A1 P22309 1/20 0.41
DPP4 P27487 1/20 0.41
ABCC1 P33527 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
CYP1A1 P04798 4/20 0.41
CYP1B1 Q16678 4/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2D6 P10635 3/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
KRAS P01116 1/20 0.41
MAPT P10636 4/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ATM Q13315 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7192091 1.00 PTPN1 (0.42) PTPN1IDH1ABCB1UGT1A1DPP4
SCHEMBL7181162 0.91 PTPN1 (0.53) PTPN1IDH1ABCB1UGT1A1DPP4
SCHEMBL7181157 0.91 PTPN1 (0.53) PTPN1IDH1ABCB1UGT1A1DPP4
SCHEMBL7185120 0.90 PTPN1 (0.41) PTPN1IDH1ABCB1UGT1A1DPP4
SCHEMBL7192096 0.89 CYP1B1 (0.44) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL7192098 0.89 CYP1B1 (0.44) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL7185664 0.89 PTPN1 (0.42) PTPN1IDH1ABCB1UGT1A1DPP4
SCHEMBL7192749 0.88 PTPN1 (0.41) PTPN1IDH1ABCB1UGT1A1DPP4
SCHEMBL7192745 0.88 PTPN1 (0.41) PTPN1IDH1ABCB1UGT1A1DPP4
SCHEMBL7190039 0.84 PTPN1 (0.44) PTPN1IDH1ABCB1UGT1A1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed